This study assesses cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders.
This randomized trial compares the effects of metformin vs placebo on weight gain in children and adolescents with autism spectrum disorder taking atypical antipsychotics.
Sullivan et al determine whether comorbid depression in patients with type 2 diabetes accelerates cognitive decline.
This systematic review and meta-analysis assesses type 2 diabetes mellitus risk associated with antipsychotic treatment in youth.
Castrén describes the network hypothesis of antidepressant action that proposes that
recovery from depression and related mood disorders is a gradual process that develops slowly and is
facilitated by structured guidance and rehabilitation.
This 22-year longitudinal study reports that women with highest number of symptoms of posttraumatic stress disorder had a nearly 2-fold increased risk of type 2 diabetes mellitus over follow-up than women with no trauma exposure.
This Viewpoint discusses the differences between patients experiencing denial and those exhibiting lack of insight and addresses interventions that may improve care for patients exhibiting lack of insight.
In a retrospective cohort study, Bobo and coauthors compare the risk of type 2 diabetes in children and youth 6 to 24 years of age for recent initiators of antipsychotic drugs vs propensity score–matched controls who had recently another psychotropic medication.